DepoMed, Inc. (DEPO) Tops Q1 EPS by 8c

May 8, 2012 5:25 PM EDT
DepoMed, Inc. (NASDAQ: DEPO) reported Q1 EPS of ($0.16), $0.08 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $12.88 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment